Winston T. Stauffer:
ORCID: https://orcid.org/0000-0001-6092-6006
Role: ConceptualizationRole: Data curationRole: InvestigationRole: MethodologyRole:
VisualizationRole: Writing – original draftRole: Writing – review & editing
Michael Bobardt: Role: Investigation
Daren R. Ure: Role: ConceptualizationRole: Formal analysisRole: Writing – review & editing
Robert T. Foster: Role: Conceptualization
Philippe Gallay:
ORCID: https://orcid.org/0000-0002-6151-4764
Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole:
ResourcesRole: Writing – review & editing
Vadim Ten: Role: Editor
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS One
Journal ID (publisher-id): plos
Title:
PLOS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
4
April
2024
Publication date Collection: 2024
Volume: 19
Issue: 4
Electronic Location Identifier: e0301711
Affiliations
[1
]
Department of Immunology & Microbiology, Scripps Research, La Jolla, California, United
States of America
[2
]
Hepion Pharmaceuticals, Edison, New Jersey, United States of America
Rutgers Robert Wood Johnson Medical School, UNITED STATES
Author notes
Competing Interests: Daren R. Ure and Robert T. Foster are employees of Hepion Pharmaceuticals, the developers
of Reconfilstat/CRV431.
Author information
Article
Publisher ID:
PONE-D-23-41197
DOI: 10.1371/journal.pone.0301711
PMC ID: 10994289
PubMed ID: 38573968
SO-VID: 13f092b7-2e11-44b6-9c10-59d171649469
Copyright © © 2024 Stauffer et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by:
funder-id http://dx.doi.org/10.13039/100006492, Division of Intramural Research, National Institute of Allergy and Infectious Diseases;
Award ID: 5R01AI143931-04
Award Recipient
: Philippe Thomas Gallay
PG 5R01AI143931-04 Funding for this study was supplied by a grant from the National
Institutes of Health/National Institute of Allergy and Infectious Diseases NIH/NIAID
https://www.niaid.nih.gov/ The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Gastroenterology and Hepatology
Subject:
Liver Diseases
Subject:
Fatty Liver
Subject:
Research and Analysis Methods
Subject:
Animal Studies
Subject:
Experimental Organism Systems
Subject:
Model Organisms
Subject:
Mouse Models
Subject:
Research and Analysis Methods
Subject:
Model Organisms
Subject:
Mouse Models
Subject:
Research and Analysis Methods
Subject:
Animal Studies
Subject:
Experimental Organism Systems
Subject:
Animal Models
Subject:
Mouse Models
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Medicine and Health Sciences
Subject:
Gastroenterology and Hepatology
Subject:
Liver Diseases
Subject:
Liver Fibrosis
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Carcinoma
Subject:
Hepatocellular Carcinoma
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Gastrointestinal Tumors
Subject:
Hepatocellular Carcinoma
Subject:
Medicine and Health Sciences
Subject:
Gastroenterology and Hepatology
Subject:
Liver Diseases
Subject:
Hepatocellular Carcinoma
Subject:
Biology and Life Sciences
Subject:
Developmental Biology
Subject:
Fibrosis
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Anatomical Pathology
Subject:
Cytopathology
Subject:
Steatosis
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Inflammation
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Inflammation
Subject:
Medicine and Health Sciences
Subject:
Clinical Medicine
Subject:
Signs and Symptoms
Subject:
Inflammation